StockNews.com Initiates Coverage on Ampio Pharmaceuticals (NYSE:AMPE)

StockNews.com initiated coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a report released on Tuesday morning. The firm issued a sell rating on the stock.

Ampio Pharmaceuticals Stock Performance

Shares of AMPE opened at $0.00 on Tuesday. The firm has a 50 day moving average price of $0.01 and a 200-day moving average price of $0.04. Ampio Pharmaceuticals has a fifty-two week low of $0.00 and a fifty-two week high of $2.91. The firm has a market cap of $2,951.00, a price-to-earnings ratio of 0.00 and a beta of 3.66.

Ampio Pharmaceuticals Company Profile

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.